Cambridge Investment Research Advisors’s Castle Biosciences CSTL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-9,102
| Closed | -$243K | – | 3532 |
|
|
2024
Q4 | $243K | Hold |
9,102
| – | – | ﹤0.01% | 3015 |
|
|
2024
Q3 | $260K | Buy |
+9,102
| New | +$260K | ﹤0.01% | 2935 |
|
|
2023
Q1 | – | Sell |
-12,501
| Closed | -$294K | – | 3173 |
|
|
2022
Q4 | $294K | Sell |
12,501
-501
| -4% | -$11.8K | ﹤0.01% | 2448 |
|
|
2022
Q3 | $339K | Hold |
13,002
| – | – | ﹤0.01% | 2265 |
|
|
2022
Q2 | $285K | Buy |
13,002
+36
| +0.3% | +$789 | ﹤0.01% | 2426 |
|
|
2022
Q1 | $582K | Buy |
12,966
+1,801
| +16% | +$80.8K | ﹤0.01% | 1985 |
|
|
2021
Q4 | $479K | Buy |
11,165
+110
| +1% | +$4.72K | ﹤0.01% | 2137 |
|
|
2021
Q3 | $735K | Sell |
11,055
-115
| -1% | -$7.65K | ﹤0.01% | 1765 |
|
|
2021
Q2 | $819K | Buy |
11,170
+3,394
| +44% | +$249K | ﹤0.01% | 1688 |
|
|
2021
Q1 | $532K | Buy |
7,776
+831
| +12% | +$56.9K | ﹤0.01% | 1862 |
|
|
2020
Q4 | $466K | Buy |
6,945
+178
| +3% | +$11.9K | ﹤0.01% | 1815 |
|
|
2020
Q3 | $348K | Buy |
+6,767
| New | +$348K | ﹤0.01% | 1835 |
|